Monday, February 9, 2026
Home Ovarian Cancer Page 3

Ovarian Cancer

Phase II randomized study of olaparib, chemotherapy, or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol.
Ovarian Cancer

Phase II randomized study of olaparib, chemotherapy, or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol.

Editorial Research Team -
0
I had 3 years to live after I was diagnosed with ovarian cancer
Ovarian Cancer

I had 3 years to live after I was diagnosed with ovarian cancer

Editorial Research Team -
0
The study suggests that ovarian cancer cells adapt to their environment to support tumor growth
Ovarian Cancer

The study suggests that ovarian cancer cells adapt to their environment to support tumor growth

Editorial Research Team -
0
primary peritoneal carcinoma
Peritoneal Cancer

Primary peritoneal carcinoma

Editorial Research Team -
0
Ovarian Cancer Patients Live Eight Years Longer: Molecular Profiling Impact
Survival

Ovarian Cancer Patients Live Eight Years Longer: Molecular Profiling Impact

Editorial Research Team -
0
123Page 3 of 3
© Newspaper WordPress Theme by TagDiv